drugset / Trial / NCT02194777
Safety, Tolerability and Pharmacokinetics of Inhalative Administration of BIBN 4096 BS in Healthy Male and Female Volunteers
RandomizedSingle-groupDouble-blindTreatment
Summary
The objective of the present study is to obtain information about the safety, tolerability and pharmacokinetics of BIBN 4096 BS after single inhalative administration of increasing doses in healthy male and female volunteers
Timeline
- Start
- 2001-06
- Primary completion
- 2001-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OLCEGEPANT | Small molecule | 5 mg | Inhaled |
| Subject | OLCEGEPANT | Small molecule | 80 mg | Inhaled |
Indications
No indication recorded.